Developer of autonomous vehicle technology focused on logistics and commercial utilization vehicles. The company specializes in sensor fusion, deep learning, planning and control algorithms, V2V/V2X networks, and energy harvesting; technologies central to intelligent driving and safe autonomous logistics, enabling autonomous solution for vehicle industrial users.
Laiye is an AI interactive platform that offers consumers and enterprises with intelligent assistant products developed with natural language processing, multi-turn dialog management, and context-based recommendation technologies. The company's main product, Wulai, enables enterprises to build chatbots. It also aims to help enterprise customers improve sales revenue, marketing ROI, and service efficiency through a business messaging and conversation solutions. Laiye was founded on 2015 and is headquartered in Beijing, China.
SyMap Medical specializes in the development and manufacturing of advanced medical devices aimed at treating hypertension and other significant health conditions, including heart failure and arrhythmia. The company focuses on a proprietary catheter-based system for renal mapping and ablation, which utilizes radiofrequency ablation technology as its core platform. This innovative approach is designed for renal denervation therapy, allowing for targeted treatment of hypertension and potentially alleviating symptoms associated with severe asthma and refractory complex arrhythmia. Through its cutting-edge solutions, SyMap Medical aims to improve patient outcomes in the management of these critical diseases.
Uniskin is a cosmetics brand that provides skin-care products suitable for the local area and people.
Hai Robotics, founded in 2016 and based in Shenzhen, China, specializes in autonomous case-handling robotic systems designed for warehouse automation. The company offers a range of intelligent solutions, including a goods-to-person system, in-plant logistics solutions, and a multi-tier steel platform, all tailored for various operational scenarios. As a pioneer in the field, Hai Robotics launched its first autonomous case-handling robotic system, HAIPICK, in 2015. This system has significantly enhanced warehouse efficiency, increasing operational performance by 3-4 times and storage density by 80%-130%. The company is committed to continuous research and development, holding numerous patents in its technology. Hai Robotics aims to provide customizable and flexible automation solutions that streamline warehousing processes, making it possible for clients to deploy automation within a week and improve overall productivity. Its clientele includes notable companies such as DHL Supply Chain, BEST Supply Chain, and Philips.
Inmagene Biopharmaceuticals Co. Ltd., founded in 2019 and headquartered in Shanghai, China, is a clinical-stage biotechnology company dedicated to researching and developing novel therapeutics for immunological and inflammatory diseases. The company focuses on creating innovative biomedical drugs to assist patients and healthcare providers in addressing immune-related conditions. Its product pipeline includes IMG-020, a protein drug designed to target IL-17A, developed by integrating Affibody’s protein therapeutics platform for enhanced potency and Albumod technology for extended half-life. Inmagene also has additional offices in Hangzhou and Beijing, China, further supporting its commitment to advancing healthcare solutions in the field of immunology.
Developer of autonomous vehicle technology focused on logistics and commercial utilization vehicles. The company specializes in sensor fusion, deep learning, planning and control algorithms, V2V/V2X networks, and energy harvesting; technologies central to intelligent driving and safe autonomous logistics, enabling autonomous solution for vehicle industrial users.
Chime Biologics Limited is a Contract Development and Manufacturing Organization (CDMO) based in Wuhan, China, established in 2013. The company specializes in providing a comprehensive range of biopharmaceutical development and manufacturing services, including drug substance and drug product manufacturing, cell line development, and protein science characterization. Chime Biologics also offers technical transfer, regulatory support, and project management services to meet the needs of the biopharmaceutical industry. The organization supports clients through all stages of development, from early drug development to late-stage clinical trials and commercial production, ensuring compliance with cGMP standards. By delivering customer-centric and cost-effective solutions, Chime Biologics aims to enhance access to affordable medicines and improve patient care.
Didi Freight
Series A in 2021
Didi Freight provides an Uber-like trucking service.
Windtree Therapeutics (formerly Discovery Laboratories) is a clinical-stage biotechnology company focused on developing novel surfactant therapies for respiratory diseases and other potential applications. Windtree proprietary technology platform includes a synthetic, peptide-containing surfactant (KL4 surfactant) that is structurally similar to endogenous pulmonary surfactant — and novel drug-delivery technologies being developed to enable noninvasive administration of aerosolized KL4 surfactant. Windtree is focused initially on improving the management of respiratory distress syndrome (RDS) in premature infants and believes that its proprietary technology may make it possible, over time, to develop a pipeline of KL4 surfactant product candidates to address a variety of respiratory diseases for which there are few or no approved therapies.
Windtree Therapeutics (formerly Discovery Laboratories) is a clinical-stage biotechnology company focused on developing novel surfactant therapies for respiratory diseases and other potential applications. Windtree proprietary technology platform includes a synthetic, peptide-containing surfactant (KL4 surfactant) that is structurally similar to endogenous pulmonary surfactant — and novel drug-delivery technologies being developed to enable noninvasive administration of aerosolized KL4 surfactant. Windtree is focused initially on improving the management of respiratory distress syndrome (RDS) in premature infants and believes that its proprietary technology may make it possible, over time, to develop a pipeline of KL4 surfactant product candidates to address a variety of respiratory diseases for which there are few or no approved therapies.
I-Mab HK is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative biologics aimed at addressing significant unmet medical needs, particularly in the areas of cancer and autoimmune disorders. The company is engaged in developing a diverse pipeline of product candidates, including Felzartamab, a CD38 antibody in Phase III trials for multiple myeloma, and Eftansomatropin, a long-acting human growth hormone for pediatric growth hormone deficiency. Other notable candidates include Olamkicept, an IL-6 blocker for ulcerative colitis, and Enoblituzumab, a B7-H3 antibody for head and neck cancer. I-Mab HK also has preclinical compounds targeting various conditions, including cancers and autoimmune diseases. The company has established strategic collaborations, such as with AbbVie, to enhance its development efforts. Founded in 2014 and headquartered in Shanghai, I-Mab HK is dedicated to advancing therapies that improve patient outcomes across various therapeutic areas.
Dingdong Maicai is a rapidly growing online retail platform based in Shanghai, China, specializing in the sale of fresh produce and daily necessities. Founded in 2014, the company leverages a big data-driven approach to optimize its operations and improve customer experience. By utilizing self-developed data models and historical sales data, Dingdong Maicai predicts future orders, which helps reduce waste and ensure product availability. The platform offers a wide range of products, including fresh vegetables, seafood, meat, fruits, and organic items. Customers can conveniently shop through the Dingdong Fresh app and mini-programs, which facilitate direct delivery to households. The company generates revenue primarily through the sale of these fresh groceries and membership services, establishing itself as a key player in the community-based e-commerce sector in China.
Bangsun Technology, based in Hangzhou, China, specializes in developing online payment security software tailored for domestic internet trading companies and financial institutions. Founded in 2010, the company offers a range of solutions, including banking and tripartite payment solutions, as well as services for bank cards, credit cards, and securities. Its product lineup features real-time transaction anti-fraud systems, Internet credit services, data analytics through machine learning, device fingerprinting, and anti-money laundering solutions. Additionally, Bangsun Technology focuses on providing comprehensive risk management services, including application anti-fraud measures and robot defense, to enhance the security of financial transactions.
New Horizon Health, founded in 2015 and headquartered in Hangzhou, China, specializes in developing advanced technologies for the detection and screening of gastrointestinal cancers, particularly gastric and colorectal cancers. The company offers innovative products based on fecal gene analysis (FIT-DNA) technology, enabling users to conduct at-home tests that identify signs of colon cancer and significant adenomas. This technology facilitates earlier detection of precancerous lesions compared to conventional blood tests. By leveraging big data and artificial intelligence, New Horizon Health enhances its cancer screening solutions, aiming to improve public health outcomes. The company also emphasizes its commitment to making early cancer screening accessible to households, thereby striving to reduce the incidence and mortality associated with cancer.
Shanghai Zhangmen Education Technology Co., Ltd. operates Zhangmen, an online tutoring platform that offers personalized tutoring courses for primary and middle school students aged eight to 18. Founded in 2014 and based in China, Zhangmen allows students to connect with highly qualified teachers who have graduated from prestigious universities such as Tsinghua, Peking University, and Fudan University. The platform provides a range of educational services, including one-on-one tutoring and comprehensive online education classes. Through its online and mobile applications, Zhangmen aims to enhance the learning experience by offering tailored educational support to meet the individual needs of each student.
Crossbar Inc. is a startup based in Santa Clara, California, specializing in the development and licensing of resistive RAM (ReRAM) technology for data storage. Founded in 2008, the company aims to revolutionize the electronics industry by providing a new class of non-volatile memory that enables significant advancements in performance and energy efficiency. Their innovative ReRAM technology allows for up to one terabyte of storage on a chip the size of a postage stamp, making it suitable for a wide range of applications, including consumer electronics, mobile devices, enterprise storage, and cloud computing. Crossbar's solutions facilitate the integration of computing and storage subsystems, enabling designs that overcome the limitations of traditional flash and DRAM memory. The company's focus on persistent and cognitive memory supports advancements in both edge and cloud computing, positioning it at the forefront of the evolving data storage landscape.
Profusa, Inc. is a digital health technology company based in Emeryville, California, specializing in the development of tissue-integrated sensors and biosensors aimed at enhancing diabetes management and chronic disease care. Founded in 2009, Profusa focuses on creating biointegrated sensors that allow individuals to monitor their unique body chemistry in real time, thereby transforming personal health management. The company's technology is designed to be user-friendly and cost-effective, providing actionable, clinical-grade data to improve health outcomes. Profusa also develops software that offers biofeedback for chronic disease management and promotes healthy living. Its flagship product, Lumee Oxygen, represents a significant advancement in continuous health monitoring within the European market.
Private Equity Round in 2018
Beijing Chemclin Biotech Co., Ltd. specializes in the development, production, and sales of diagnostic reagents and instruments for clinical use. Founded in 1999 and based in Beijing, China, the company focuses on in-vitro diagnostics, offering a range of products including reagents for infectious diseases, tumor markers, and thyroid and diabetes testing. Chemclin also provides semi-automated and fully automated chemiluminescent analyzers, which facilitate the performance of chemiluminescent assays. Additionally, the company offers commercial testing services for various health conditions, including liver fibrosis and fertility. As a subsidiary of China Diagnostics Medical Corporation, Chemclin is committed to delivering innovative diagnostic solutions and services to the Chinese healthcare market.
TalkingData’s advanced data statistics and analytic software have reached nearly 1.5 billion mobile devices in China, providing the most data-rich, reliable and profound market reports from benchmark KPIs, to user behavior studies, to industry movements, trends, and forecasts. Our insightful reports can provide you powerful insights into the Chinese Mobile Internet market. TalkingData offers the best-in-class Big Data products varying from highly-scalable data mining, deep data analytics, DMP (Data Management Platform), analytical reports, industry benchmarking, and deep-dive market insight reports. Today, 80% of the Top 50 developers in China rely on us to track their app metrics, analyze user data points, and monetization. Talkingdata was established in Sep. 2011 in Beijing. The Company finished Series A/B funding rounds of over tens of millions of dollars in 2013 and 2014 respectively. After nearly 4 years of rapid development, we now have close collaboration with 90% of the Top 10 distribution channels (Mobile app stores) and Top 10 Ad Networks in China. We are also developing cross-border cooperation with financial and other traditional industries.
Renrui Human Resources Technology Holdings Limited, an investment holding company, provides human resource solutions in China. The company operates through Flexible Staffing, Professional Recruitment, and Other HR Solutions segments. It operates online to offline recruitment platform in flexible staffing market. The company offers talent outsourcing; senior talent management; and professional recruitment services, including membership, negotiation, on-boarding management, and on-site recruitment. It also provides business process outsourcing services, such as performance management, operations management, training management, information security, and scheduling management, as well as labor dispatch and corporate training services. The company was founded in 2010 and is headquartered in Chengdu, China.
Eden Biologics is a biopharmaceutical company founded in 2012 and headquartered in Zhubei City, Taiwan. The company specializes in contract development and manufacturing services aimed at accelerating the development programs of its partners in the biopharmaceutical sector. It offers a comprehensive range of services, including cell line development, process development, analytical services, formulation development, and cGMP manufacturing. Eden Biologics is committed to making high-quality biologic medicines affordable and accessible by leveraging advanced process and engineering technologies that simplify and reduce the costs associated with mammalian cell culture manufacturing. The company operates state-of-the-art manufacturing facilities in Asia, adhering to US, EU, and ICH cGMP regulations, and is led by a team of experienced professionals with backgrounds in leading biopharmaceutical companies.
Youdao, Inc. is an internet technology company based in Hangzhou, China, that specializes in providing a range of online services focused on content, community, communication, and commerce. Founded in 2006, the company offers various learning resources through its mobile applications and websites, catering to diverse age groups from preschool to adult learners. Its key products include the Youdao Dictionary, Youdao Cloudnote, and a suite of dictionary and translation tools like Youdao Translation and U-Dictionary. Youdao also develops smart devices such as the Youdao Smart Pen and Pocket Translator. The company operates in three main segments: Learning services, which is its primary revenue source, Smart devices, and Online marketing services. Learning services encompass online courses and fee-based premium content, while the smart devices segment includes the sale of educational tools. Youdao operates as a subsidiary of NetEase, enhancing its capabilities through advanced technology and data-driven solutions.
Pony.ai, Inc. is a company that specializes in developing artificial intelligence software for autonomous mobility applications. Founded in 2016 by James Peng and Tiancheng Lou, Pony.ai is headquartered in Fremont, California, with additional offices in San Francisco and in China. The company creates full-stack autonomous driving solutions that enhance the manufacturing of automated vehicles. Its technology utilizes advanced algorithms and AI to accurately interpret the vehicle's environment, enabling it to predict the actions of surrounding drivers and navigate safely. In addition to its software solutions, Pony.ai operates a public-facing Robotaxi service, further demonstrating its commitment to advancing autonomous transportation.
Meicai operates an online platform that connects farmers directly with restaurants, effectively streamlining the agricultural supply chain. By eliminating middlemen, the platform allows businesses to order fresh produce directly from farms, facilitating a more efficient distribution process. This model not only benefits restaurants by providing access to high-quality agricultural products but also supports farmers by enabling them to sell their vegetables directly to end-users. Through its innovative approach, Meicai aims to enhance the fresh food marketplace and improve the overall dynamics of agricultural distribution.
Keyssa, Inc. specializes in the development and manufacturing of contactless connectors and wireless semiconductors utilizing millimeter-wave technology for data transfer. The company offers a compact system known as Kiss Connectivity, which facilitates simple, secure, and instantaneous data flow between devices without the need for metal connectors, cables, or traditional wireless networks. This innovative solution enables rapid transmission of large amounts of data and video between devices in close proximity while minimizing battery drain. Keyssa's technology relies on extremely high frequency signals and integrates advanced mechanical design, electromagnetics, materials science, and semiconductor technologies. Founded in 2009 and originally known as WaveConnex, Inc., Keyssa is headquartered in Campbell, California, with additional offices in Oregon, China, South Korea, and Taiwan.
Gamida Cell Ltd. is a clinical-stage biopharmaceutical company focused on developing innovative cell therapies for blood cancers and serious blood diseases. The company's lead product candidate, omidubicel, utilizes expanded hematopoietic stem cells and differentiated immune cells, and is currently undergoing Phase 3 trials for high-risk hematologic malignancies, alongside Phase 1/2 trials for severe aplastic anemia. Additionally, Gamida Cell is advancing GDA-201, a natural killer cell-based immunotherapy, which is in Phase 1/2 studies for relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. Founded in 1998 and headquartered in Jerusalem, Israel, the company leverages a proprietary expansion platform that enhances the therapeutic potential of umbilical cord blood-derived cells and natural killer cells, aiming to address significant unmet clinical needs in the field of regenerative medicine.
Souche, a leading automotive new retail platform in China, is founded by Mr. Yao Junhong, the former CAR Inc. founding team member and vice president, in December, 2012. By August 2018, Souche raised over $1.2 billion from investment or ganizations, including Alibaba group, Ant Financial Services Group, Morningside Venture Capital, Warburg Pincus, Primavera Capital Group, etc. Souche joined '2017 New Global Unicorns Ranking' by Silicon Valley global research organization PitchBook. Souche thrives to become the big intelligent brain of automotive industry. Souche has gradually constructed integrated automotive new retail ecosystem through years of development. Souche is regarded as 'the Alibaba of Chinese automotive industry'. Today, Souche and its relative corporations dedicate in numerous businesses, which include automotive financial leasing platform Tangeche, B2B industrial chain service platform Chehang168, Used-car online trade platform Cheyipai, Car sharing customized platform TIHD, SaaS products for used-car automotive dealers Dafengche and new-car sub-channels automotive dealership network Maicheguanjia, automotive dealership group ERP system provider Breakthrough, Kingdee and automotive supply chain warehouse logistics integrated service provider Iyunche, etc.
iQIYI, Inc. is a leading online entertainment provider in China, offering a diverse range of services including internet video, online games, live broadcasting, online literature, animations, and e-commerce. The platform features a vast library of licensed and self-produced video content, catering to the preferences of its users. Additionally, iQIYI provides membership options, content distribution, and online advertising services. The company operates various subsidiaries, including iQIYI Mall, which focuses on entertainment-related merchandise, and iQIYI Show, a live broadcasting service that connects users with popular hosts and celebrities. iQIYI Paopao serves as an entertainment-based social media platform, while the company also engages in talent agency and intellectual property licensing. Founded in 2009 and headquartered in Beijing, iQIYI was formerly known as Qiyi.com and rebranded in 2011. The company is a subsidiary of Baidu Holdings Limited and continues to compete with other major platforms in the industry.
Private Equity Round in 2015
Pharmaron Beijing Co., Ltd. is a leading provider of research and development services for the pharmaceutical industry, serving clients across North America, Europe, Asia, and beyond. Established in 2004 and headquartered in Beijing, the company operates through four main segments: Laboratory Services, Manufacturing and Controls Services, Clinical Development, and Others. Pharmaron offers a comprehensive range of services, including laboratory chemistry, drug metabolism and pharmacokinetics, in vitro biology, safety assessments, process development, and formulation manufacturing. Additionally, the company specializes in clinical research, regulatory bioanalysis, and contract research services. By investing in its workforce and facilities, Pharmaron has positioned itself to meet the evolving needs of the life sciences sector, thereby facilitating the development and manufacturing of pharmaceutical products globally.
Private Equity Round in 2015
Guangzhou Kingmed Diagnostics Group Co., Ltd. is a leading independent clinical laboratory in China, founded in 1994 and headquartered in Guangzhou. The company operates 49 centralized laboratories and offers a comprehensive range of over 4,000 medical examination and clinical diagnostic services. It serves approximately 21,000 medical institutions across densely populated regions in the country, with over 90% of its revenue derived from clinical diagnostics. KingMed also provides food and hygiene testing, as well as scientific research services. To enhance its capabilities, the company has formed a strategic partnership with Personal Genome Diagnostics Inc. to address the clinical trial screening needs of pharmaceutical partners in the Asian market. In recent years, KingMed has focused on investing in cold chain logistics to improve service delivery.
UCloud Information Technology specializes in cloud computing solutions, offering a comprehensive range of services designed to support various sectors including video, e-commerce, internet finance, and online education. Founded in 2011 and headquartered in Shanghai, the company develops and provides infrastructure as a service (IaaS), platform as a service (PaaS), and various cloud-based products. Its offerings include UCloud Physical Host for dedicated servers, UCloud Host for cloud computing, UCloud Load Balancer for distributing application data, and UCloud Extended Hybrid Cloud for integrated cloud and server hosting solutions. Additionally, UCloud provides data storage options through UCloud Disk, UCloud DataBase, and UCloud Memory Storage, along with content delivery network services and cloud security solutions. The company's focus on independent research and development enhances its capabilities in data analysis, artificial intelligence, and Internet of Things applications, ensuring robust support for its clients' diverse IT infrastructure needs.
FinVolution Group, formerly known as PPDai, is an online platform for peer-to-peer small unsecured loans in China. It builds a safe, high-performance, honest network platform with creative technology and ideals. FinVolution Group standardizes personal behaviors of debit and credit and brings returns to both lenders and borrowers. FinVolution was founded in August 2007 by founders from well-known companies.